{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:11:02Z","timestamp":1793315462997,"version":"4.5.0"},"reference-count":31,"publisher":"Informa UK Limited","issue":"5","license":[{"start":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T00:00:00Z","timestamp":1617321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2021,5,4]]},"DOI":"10.1080\/03007995.2021.1896489","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T09:19:32Z","timestamp":1616059172000},"page":"801-809","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["An indirect comparison between bosutinib, nilotinib and dasatinib in first-line chronic phase chronic myeloid leukemia"],"prefix":"10.1080","volume":"37","author":[{"given":"Bogdan","family":"Muresan","sequence":"first","affiliation":[{"name":"Ingress Health, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5321-561X","authenticated-orcid":false,"given":"Carla","family":"Mamolo","sequence":"additional","affiliation":[{"name":"Pfizer Inc., Groton, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph C.","family":"Cappelleri","sequence":"additional","affiliation":[{"name":"Pfizer Inc., Groton, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Leip","sequence":"additional","affiliation":[{"name":"Pfizer Inc., Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Viqueira","sequence":"additional","affiliation":[{"name":"Pfizer SLU, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Heeg","sequence":"additional","affiliation":[{"name":"Ingress Health, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,4,2]]},"reference":[{"key":"CIT0001","unstructured":"Cancer net; 2019 [cited July 21, 2019]. Available from https:\/\/www.cancer.net\/cancer-types\/leukemia-chronic-myeloid-cml\/statistics."},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.66.2866"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0912614"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002315"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.74.7162"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S177566"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.7522"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2018.08.016"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.17265\/2159-5313\/2016.09.003"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70201-7"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-376087"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.05.004"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-015-0271-1"},{"key":"CIT0014","unstructured":"European Medicines Agency. Summary of product characteristics: Tasigna (nilotinib); 2019. Available from https:\/\/www.ema.europa.eu\/documents\/product-information\/tasigna-epar-product-information_en.pdf."},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2014.977992"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.17265\/2159-5313\/2016.09.003"},{"key":"CIT0017","unstructured":"ClinicalTrial.gov website; identifier numbers: NCT00481247; CA 180-056; February 2017 [cited 2020 Feb 19]. https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT00481247?view=results."},{"key":"CIT0018","first-page":"46","volume":"72","author":"Bendel RB","year":"1977","journal-title":"J Am Stat Assoc"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a115101"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.17265\/2159-5313\/2016.09.003"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X17725740"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2011.576238"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2019.1605239"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.116"},{"key":"CIT0025","unstructured":"NCCN clinical practice guidelines in oncology (NCCN guidelines). Chronic myeloid leukemia, version 1.2019 \u2013 August 1, 2018."},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2010.07.003"},{"issue":"2","key":"CIT0027","first-page":"587","volume":"111","author":"Bonifazi F","year":"2000","journal-title":"Br J Haematol"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0776-2"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0912614"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002315"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.74.7162"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2021.1896489","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T09:56:50Z","timestamp":1637143010000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03007995.2021.1896489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,2]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5,4]]}},"alternative-id":["10.1080\/03007995.2021.1896489"],"URL":"https:\/\/doi.org\/10.1080\/03007995.2021.1896489","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-11-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}